Answers are grounded in this paper and cite their sources.
-acetyl galactosamine (GalNAc) ligands to deliver a therapeutic effect, underscoring the value of targeting moieties. In this review, we explore the history of GalNAc as a ligand, and the paradigm it has set for the delivery of NATs through precise targeting to the liver, overcoming common hindrances faced with this type of therapy. We describe various complex oligosaccharides (OSs) and ask what others could be used to target receptors for NAT delivery and the opportunities awaiting exploration of this chemical space.
No takes yet. Share an insight, caveat, or question.
O'Sullivan et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: